-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, PKv29S5oMUP++9u1PUG0aAlz6wFRLbJOC40yswfvuJTSTGit8/M6W7ryBPYe9n/O jJuU3RMt8Y9cIj+KjJU+1g== 0001104659-09-048688.txt : 20090810 0001104659-09-048688.hdr.sgml : 20090810 20090810170410 ACCESSION NUMBER: 0001104659-09-048688 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 4 CONFORMED PERIOD OF REPORT: 20090807 FILED AS OF DATE: 20090810 DATE AS OF CHANGE: 20090810 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LANDY JOSEPH CENTRAL INDEX KEY: 0001220638 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31577 FILM NUMBER: 091000724 MAIL ADDRESS: STREET 1: C/O WARBURG PINCUS LLC STREET 2: 466 LEXINGTON AVE CITY: NEW YORK STATE: NY ZIP: 10017 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KAYE CHARLES R CENTRAL INDEX KEY: 0001239318 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31577 FILM NUMBER: 091000725 MAIL ADDRESS: STREET 1: C/O WARBURG PINCUS LLC STREET 2: 466 LEXINGTON AVE CITY: NEW YORK STATE: NY ZIP: 10017 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INSPIRE PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001040416 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043209022 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4222 EMPEROR BLVD STE 200 CITY: DURHAM STATE: NC ZIP: 27703-8466 BUSINESS PHONE: 9199419777 MAIL ADDRESS: STREET 1: 4222 EMPEROR BLVD STREET 2: STE 200 CITY: DURHAM STATE: NC ZIP: 27703-8466 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WARBURG PINCUS & CO CENTRAL INDEX KEY: 0000929408 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31577 FILM NUMBER: 091000726 BUSINESS ADDRESS: STREET 1: 466 LEXINGTON AVENUE CITY: NEW YORK STATE: NY ZIP: 100173147 BUSINESS PHONE: 2128780600 MAIL ADDRESS: STREET 1: 466 LEXINGTON AVENUE STREET 2: NEW YORK CITY: NY STATE: NY ZIP: 100173147 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WARBURG PINCUS LLC CENTRAL INDEX KEY: 0001162870 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31577 FILM NUMBER: 091000727 BUSINESS ADDRESS: STREET 1: 466 LEXINGTON AVENUE CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: 2128780600 MAIL ADDRESS: STREET 1: 466 LEXINGTON AVENUE CITY: NEW YORK STATE: NY ZIP: 10017 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Warburg Pincus Partners LLC CENTRAL INDEX KEY: 0001322709 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31577 FILM NUMBER: 091000728 BUSINESS ADDRESS: STREET 1: 466 LEXINGTON AVENUE CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: 212-878-0600 MAIL ADDRESS: STREET 1: 466 LEXINGTON AVENUE CITY: NEW YORK STATE: NY ZIP: 10017 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Warburg Pincus Private Equity IX, L.P. CENTRAL INDEX KEY: 0001332737 FISCAL YEAR END: 1204 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31577 FILM NUMBER: 091000729 BUSINESS ADDRESS: STREET 1: C/O WARBURG PINCUS LLC STREET 2: 466 LEXINGTON AVENUE CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: 212-878-0600 MAIL ADDRESS: STREET 1: C/O WARBURG PINCUS LLC STREET 2: 466 LEXINGTON AVENUE CITY: NEW YORK STATE: NY ZIP: 10017 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Warburg Pincus IX LLC CENTRAL INDEX KEY: 0001342445 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31577 FILM NUMBER: 091000730 BUSINESS ADDRESS: STREET 1: 466 LEXINGTON AVENUE CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: 212-878-0600 MAIL ADDRESS: STREET 1: 466 LEXINGTON AVENUE CITY: NEW YORK STATE: NY ZIP: 10017 4 1 a4.xml 4 X0303 4 2009-08-07 0 0001040416 INSPIRE PHARMACEUTICALS INC ISPH 0001332737 Warburg Pincus Private Equity IX, L.P. C/O WARBURG PINCUS LLC 450 LEXINGTON AVENUE NEW YORK NY 10017 0 0 1 0 0001322709 Warburg Pincus Partners LLC C/O WARBURG PINCUS LLC 450 LEXINGTON AVENUE NEW YORK NY 10017 0 0 1 0 0001162870 WARBURG PINCUS LLC C/O WARBURG PINCUS LLC 450 LEXINGTON AVENUE NEW YORK NY 10017 0 0 1 0 0000929408 WARBURG PINCUS & CO C/O WARBURG PINCUS LLC 450 LEXINGTON AVENUE NEW YORK NY 10017 0 0 1 0 0001239318 KAYE CHARLES R C/O WARBURG PINCUS LLC 450 LEXINGTON AVENUE NEW YORK NY 10017 0 0 1 0 0001220638 LANDY JOSEPH C/O WARBURG PINCUS LLC 450 LEXINGTON AVENUE NEW YORK NY 10017 0 0 1 0 0001342445 Warburg Pincus IX LLC C/O WARBURG PINCUS LLC 450 LEXINGTON AVENUE NEW YORK NY 10017 0 0 1 0 Common Stock, par value $0.001 per share 2009-08-10 4 P 0 8888888 4.50 A 22907488 D See Exhibit 99.1 Exhibit List: Exhibit 99.1 - Explanation of Responses,, Exhibit 99.2 - Joint Filers' Names and Addresses, Exhibit 99.3 - Joint Filers' Signatures WARBURG PINCUS PRIVATE EQUITY IX, L.P., By: Warburg Pincus IX LLC, its General Partner, By: Warburg Pincus Partners, LLC, its Sole Member, By: Warburg Pincus and Co., its Managing Member By: /s/ Scott A. Arenare, Partner 2009-08-10 EX-99.1 2 ex-99d1.htm EX-99.1

Exhibit 99.1

Designated Filer: Warburg Pincus Private Equity IX, L.P.

Issuer and Ticker Symbol: Inspire Pharmaceuticals, Inc. [ISPH]

Date of Event Requiring Statement: August 10, 2009

EXPLANATION OF RESPONSES

On August 10, 2009, in connection with the closing of an underwritten public offering of shares of the common stock, par value $0.001 per share (the “Common Stock”), of Inspire Pharmaceuticals, Inc. (the “Company”), Warburg Pincus Private Equity IX, L.P., a Delaware limited partnership (“WP IX”), purchased 8,888,888 shares of the Common Stock at the public offering price of $4.50 per share.

All of the shares of the Common Stock disclosed in this Form 4 are owned by WP IX. The sole general partner of WP IX is Warburg Pincus IX, LLC, a New York limited liability company (“WP IX LLC”). Warburg Pincus Partners LLC, a New York limited liability company (“WPP LLC”), is the sole member of WP IX LLC. Warburg Pincus & Co., a New York general partnership (“WP”), is the managing member of WPP LLC. Warburg Pincus LLC, a New York limited liability company (“WP LLC”), manages WP IX. Charles R. Kaye and Joseph P. Landy are each Managing General Partners of WP and Co-Presidents and Managing Members of WP LLC. By reason of the provisions of Rule 16a-1 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), WP, WP LLC, WPP LLC, WP IX LLC, Mr. Kaye and Mr. Landy may be deemed to be the beneficial owners of any securities that may be deemed to be owned by WP IX. Each of WP, WP LLC, WPP LLC, WP IX LLC, Mr. Kaye and Mr. Landy disclaims beneficial ownership of such securities except to the extent of any indirect pecuniary interest therein. The address of the Warburg Pincus Entities is 450 Lexington Avenue, New York, New York 10017.

EX-99.2 3 ex-99d2.htm EX-99.2

Exhibit 99.2

Designated Filer: Warburg Pincus Private Equity IX, L.P.

Issuer and Ticker Symbol: Inspire Pharmaceuticals, Inc. [ISPH]

Date of Event Requiring Statement: August 10, 2009

JOINT FILERS’ NAMES AND ADDRESSES

1. Name: Warburg Pincus IX LLC

Address: c/o Warburg Pincus LLC

450 Lexington Avenue

New York, NY 10017

2. Name: Warburg Pincus Partners LLC

Address: c/o Warburg Pincus LLC

450 Lexington Avenue

New York, NY 10017

3. Name: Warburg Pincus LLC

Address: 450 Lexington Avenue

New York, NY 10017

4. Name: Warburg Pincus & Co.

Address: c/o Warburg Pincus LLC

450 Lexington Avenue

New York, NY 10017

5. Name: Charles R. Kaye

Address: c/o Warburg Pincus LLC

450 Lexington Avenue

New York, NY 10017

6. Name: Joseph P. Landy

Address: c/o Warburg Pincus LLC

450 Lexington Avenue

New York, NY 10017

EX-99.3 4 ex-99d3.htm EX-99.3

Exhibit 99.3

Designated Filer: Warburg Pincus Private Equity IX, L.P.

Issuer and Ticker Symbol: Inspire Pharmaceuticals, Inc. [ISPH]

Date of Event Requiring Statement: August 10, 2009

JOINT FILERS’ SIGNATURES

WARBURG PINCUS IX, LLC

By: Warburg Pincus Partners, LLC, its Sole Member
By: Warburg Pincus & Co., its Managing Member

By:	/s/ Scott A. Arenare		Date:	August 10, 2009
	Name: Scott A. Arenare
	Title: Partner

WARBURG PINCUS PARTNERS, LLC

By: Warburg Pincus & Co., its Managing Member

By:	/s/ Scott A. Arenare		Date:	August 10, 2009
	Name: Scott A. Arenare
	Title: Partner

WARBURG PINCUS LLC

By:	/s/ Scott A. Arenare		Date:	August 10, 2009
	Name: Scott A. Arenare
	Title: Managing Director

WARBURG PINCUS & CO.

By:	/s/ Scott A. Arenare		Date:	August 10, 2009
	Name: Scott A. Arenare
	Title: Partner

By:	/s/ Scott A. Arenare		Date:	August 10, 2009
	Name: Charles R. Kaye
	By: Scott A. Arenare, Attorney-in-Fact*

By:	/s/ Scott A. Arenare		Date:	August 10, 2009
	Name: Joseph P. Landy
	By: Scott A. Arenare, Attorney-in-Fact**

* Power of Attorney given by Mr. Kaye was previously filed with the Securities and Exchange Commission on March 2, 2006 as an exhibit to a Schedule 13D filed by Building Products, LLC with respect to Builders FirstSource, Inc.

** Power of Attorney given by Mr. Landy was previously filed with the Securities and Exchange Commission on March 2, 2006 as an exhibit to a Schedule 13D filed by Building Products, LLC with respect to Builders FirstSource, Inc.

-----END PRIVACY-ENHANCED MESSAGE-----